Importance: It is important to identify features of polypoidal choroidal vasculopathy (PCV) that differentiate it from typical neovascular age-related macular degeneration (nAMD) on various imaging modalities, including fluorescein angiography (FA).

Background: PCV was thought to be indistinguishable from nAMD using FA alone. In real-world practice, indocyanine-green angiography may often be unavailable or contraindicated.

Design: Analysis of FA images from a prospective, multicentre study.

Participants: Study images of both PCV and nAMD patients from the EVEREST study.

Methods: FA features at baseline were independently graded by masked graders (fellowship-trained ophthalmologists) using standardized diagnostic algorithms.

Main Outcome Measures: Predictive indicators (sensitivity, specificity, positive and negative predictive values) for PCV.

Results: Of the 95 patients screened, 61 had PCV. Of the 34 screening failures, 15 were diagnosed as nAMD. Hyperfluorescent nodules on FA were observed in 80% of patients with PCV vs 20% with nAMD (P < 0.001). Blocked fluorescence on FA, which corresponded to the presence of subretinal haemorrhage, occurred more frequently among patients with PCV vs nAMD (61.7% vs 13.3%, P = 0.001). Similarly, the leakage characteristic of occult choroidal neovascularization occurred more frequently among patients with PCV vs nAMD (95.0% vs 73.3%, P = 0.026). The positive predictive value for PCV was 94.1% for hyperfluorescent nodules, 94.9% for blocked fluorescence, 83.8% for occult choroidal neovascularization and 82.0% for pigment epithelial detachment.

Conclusions And Relevance: This study demonstrated that certain FA features can be predictive of PCV and may be considered as an indication for retina specialists to perform indocyanine green angiography as confirmatory test.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767036PMC
http://dx.doi.org/10.1111/ceo.13464DOI Listing

Publication Analysis

Top Keywords

pcv namd
12
patients pcv
12
pcv
9
fluorescein angiography
8
features predictive
8
polypoidal choroidal
8
choroidal vasculopathy
8
hyperfluorescent nodules
8
blocked fluorescence
8
occurred frequently
8

Similar Publications

Purpose: A projection-resolved optical coherence tomography angiography (PR-OCTA) algorithm with slab-specific strategy was applied in polypoidal choroidal vasculopathy (PCV) to differentiate between polyp and branching vascular network (BVN) and improve polyp detection by en face OCTA.

Methods: Twenty-nine participants diagnosed with PCV by indocyanine green angiography (ICGA) and 30 participants diagnosed with typical neovascular age-related macular degeneration (nAMD) were enrolled. Polyps were classified into three categories after using the slab-specific PR algorithm.

View Article and Find Full Text PDF

Background: To compare the visual and anatomical outcomes of pneumatic displacement (PD) combined with anti-vascular endothelial growth factor (VEGF) therapy versus anti-VEGF monotherapy in treatment-naive eyes with submacular haemorrhage (SMH) secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Methods: In a retrospective comparative interventional study of 57 eyes, the changes in logMAR visual acuity (VA), and SMH height and area at baseline at months 1, 3 and 12 were compared between the PD and non-PD groups.

Results: There was no significant difference in mean VA in the PD versus non-PD group at month 12 (1.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the cost-effectiveness of anti-VEGF therapies for neovascular age-related macular degeneration (nAMD), focusing on societal and patient perspectives in Japan.
  • A Markov model simulated treatment outcomes for various subtypes of nAMD, comparing ranibizumab biosimilar to aflibercept and other treatment regimens in terms of quality-adjusted life years (QALYs) and costs.
  • Results showed that ranibizumab biosimilar had varying incremental QALYs and costs depending on the nAMD subtype and perspective, indicating a complex evaluation of its economic value relative to other treatments.
View Article and Find Full Text PDF

Purpose: To describe the early experiences of patients with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) whose treatment was switched to faricimab from other anti-vascular endothelial growth factor (VEGF) agents.

Methods: This is a prospective cohort of eyes with nAMD and PCV that were previously treated with anti-VEGF agents other than faricimab. We evaluated visual acuity (VA), central subfield thickness (CST), macular volume (MV), pigment epithelial detachment (PED) height, and choroidal thickness (CT) after one administration of faricimab.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the long-term effectiveness and safety of brolucizumab (BRZ) injections in patients with typical neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV).
  • It included 401 patients over a follow-up period of at least 12 months, assessing visual acuity, retinal fluid, and central subfield thickness (CST), with positive results noted across both patient groups.
  • Brolucizumab maintained visual acuity and significantly improved retinal fluid management; however, there were instances of intraocular inflammation, with some cases leading to severe complications after treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!